-
Je něco špatně v tomto záznamu ?
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology
PM. Seferović, M. Polovina, J. Bauersachs, M. Arad, TB. Gal, LH. Lund, SB. Felix, E. Arbustini, ALP. Caforio, D. Farmakis, GS. Filippatos, E. Gialafos, V. Kanjuh, G. Krljanac, G. Limongelli, A. Linhart, AR. Lyon, R. Maksimović, D. Miličić, I....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
Medline Complete (EBSCOhost)
od 2000-03-01 do Před 1 rokem
Wiley Free Content
od 1999 do Před 1 rokem
PubMed
30989768
DOI
10.1002/ejhf.1461
Knihovny.cz E-zdroje
- MeSH
- dilatační kardiomyopatie komplikace patofyziologie terapie MeSH
- hypertrofická kardiomyopatie komplikace patofyziologie terapie MeSH
- kardiomyopatie komplikace patofyziologie terapie MeSH
- kardiovaskulární komplikace v těhotenství patofyziologie terapie MeSH
- lidé MeSH
- management nemoci MeSH
- poruchy v puerperiu patofyziologie terapie MeSH
- progrese nemoci MeSH
- restriktivní kardiomyopatie komplikace patofyziologie terapie MeSH
- srdeční selhání epidemiologie etiologie patofyziologie terapie MeSH
- těhotenství MeSH
- tepový objem MeSH
- transplantace srdce MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural history of HF in cardiomyopathies is limited, and distinct features of their therapeutic responses have not been systematically addressed. Therefore, this position paper focuses on epidemiology, pathophysiology, natural history and latest developments in treatment of HF in patients with dilated (DCM), hypertrophic (HCM) and restrictive (RCM) cardiomyopathies. In DCM, HF with reduced ejection fraction (HFrEF) has high incidence and prevalence and represents the most frequent cause of death, despite improvements in treatment. In addition, advanced HF in DCM is one of the leading indications for heart transplantation. In HCM, HF with preserved ejection (HFpEF) affects most patients with obstructive, and ∼10% of patients with non-obstructive HCM. A timely treatment is important, since development of advanced HF, although rare in HCM, portends a poor prognosis. In RCM, HFpEF is common, while HFrEF occurs later and more frequently in amyloidosis or iron overload/haemochromatosis. Irrespective of RCM aetiology, HF is a harbinger of a poor outcome. Recent advances in our understanding of the mechanisms underlying the development of HF in cardiomyopathies have significant implications for therapeutic decision-making. In addition, new aetiology-specific treatment options (e.g. enzyme replacement therapy, transthyretin stabilizers, immunoadsorption, immunotherapy, etc.) have shown a potential to improve outcomes. Still, causative therapies of many cardiomyopathies are lacking, highlighting the need for the development of effective strategies to prevent and treat HF in cardiomyopathies.
Cardiology Department Centro Hospitalar São João Porto Portugal
Department of Cardiology and Angiology Medical School Hannover Hannover Germany
Department of Cardiology Clinical Center of Serbia Belgrade Serbia
Department of Cardiology Hacettepe University Faculty of Medicine Ankara Turkey
Department of Cardiology IRCCS San Raffaele Pisana Rome Italy
Department of Cardiology University Heart Center Zürich Switzerland
Department of Cardiovascular Surgery Dokuz Eylül University Faculty of Medicine İzmir Turkey
Department of Internal Medicine B University Medicine Greifswald Greifswald Germany
Heart Failure Unit Cardiology G da Saliceto Hospital Piacenza Italy
National Heart and Lung Institute Imperial College London and Royal Brompton Hospital London UK
School of Nursing and Midwifery Queen's University Belfast Belfast UK
Serbian Academy of Sciences and Arts Belgrade Serbia
University of Cyprus Medical School Nicosia Cyprus
Volgograd State Medical University Regional Cardiology Centre Volgograd Volgograd Russia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025868
- 003
- CZ-PrNML
- 005
- 20230131101218.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ejhf.1461 $2 doi
- 035 __
- $a (PubMed)30989768
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Seferović, Petar M $u University of Belgrade Faculty of Medicine, Belgrade, Serbia. Serbian Academy of Sciences and Arts, Belgrade, Serbia.
- 245 10
- $a Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology / $c PM. Seferović, M. Polovina, J. Bauersachs, M. Arad, TB. Gal, LH. Lund, SB. Felix, E. Arbustini, ALP. Caforio, D. Farmakis, GS. Filippatos, E. Gialafos, V. Kanjuh, G. Krljanac, G. Limongelli, A. Linhart, AR. Lyon, R. Maksimović, D. Miličić, I. Milinković, M. Noutsias, A. Oto, Ö. Oto, SU. Pavlović, MF. Piepoli, AD. Ristić, GMC. Rosano, H. Seggewiss, M. Ašanin, JP. Seferović, F. Ruschitzka, J. Čelutkiene, T. Jaarsma, C. Mueller, B. Moura, L. Hill, M. Volterrani, Y. Lopatin, M. Metra, J. Backs, W. Mullens, O. Chioncel, RA. de Boer, S. Anker, C. Rapezzi, AJS. Coats, C. Tschöpe,
- 520 9_
- $a Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural history of HF in cardiomyopathies is limited, and distinct features of their therapeutic responses have not been systematically addressed. Therefore, this position paper focuses on epidemiology, pathophysiology, natural history and latest developments in treatment of HF in patients with dilated (DCM), hypertrophic (HCM) and restrictive (RCM) cardiomyopathies. In DCM, HF with reduced ejection fraction (HFrEF) has high incidence and prevalence and represents the most frequent cause of death, despite improvements in treatment. In addition, advanced HF in DCM is one of the leading indications for heart transplantation. In HCM, HF with preserved ejection (HFpEF) affects most patients with obstructive, and ∼10% of patients with non-obstructive HCM. A timely treatment is important, since development of advanced HF, although rare in HCM, portends a poor prognosis. In RCM, HFpEF is common, while HFrEF occurs later and more frequently in amyloidosis or iron overload/haemochromatosis. Irrespective of RCM aetiology, HF is a harbinger of a poor outcome. Recent advances in our understanding of the mechanisms underlying the development of HF in cardiomyopathies have significant implications for therapeutic decision-making. In addition, new aetiology-specific treatment options (e.g. enzyme replacement therapy, transthyretin stabilizers, immunoadsorption, immunotherapy, etc.) have shown a potential to improve outcomes. Still, causative therapies of many cardiomyopathies are lacking, highlighting the need for the development of effective strategies to prevent and treat HF in cardiomyopathies.
- 650 _2
- $a kardiomyopatie $x komplikace $x patofyziologie $x terapie $7 D009202
- 650 _2
- $a dilatační kardiomyopatie $x komplikace $x patofyziologie $x terapie $7 D002311
- 650 _2
- $a hypertrofická kardiomyopatie $x komplikace $x patofyziologie $x terapie $7 D002312
- 650 _2
- $a restriktivní kardiomyopatie $x komplikace $x patofyziologie $x terapie $7 D002313
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční selhání $x epidemiologie $x etiologie $x patofyziologie $x terapie $7 D006333
- 650 _2
- $a transplantace srdce $7 D016027
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a kardiovaskulární komplikace v těhotenství $x patofyziologie $x terapie $7 D011249
- 650 _2
- $a poruchy v puerperiu $x patofyziologie $x terapie $7 D011644
- 650 _2
- $a tepový objem $7 D013318
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Polovina, Marija $u University of Belgrade Faculty of Medicine, Belgrade, Serbia. Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
- 700 1_
- $a Bauersachs, Johann $u Department of Cardiology and Angiology, Medical School Hannover, Hannover, Germany.
- 700 1_
- $a Arad, Michael $u Cardiomyopathy Clinic and Heart Failure Institute, Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- 700 1_
- $a Gal, Tuvia Ben $u Department of Cardiology, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- 700 1_
- $a Lund, Lars H $u Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Felix, Stephan B $u Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.
- 700 1_
- $a Arbustini, Eloisa $u Centre for Inherited Cardiovascular Diseases, IRCCS Foundation, University Hospital Policlinico San Matteo, Pavia, Italy.
- 700 1_
- $a Caforio, Alida L P $u Division of Cardiology, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.
- 700 1_
- $a Farmakis, Dimitrios $u University of Cyprus Medical School, Nicosia, Cyprus; Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece. $7 xx0281405
- 700 1_
- $a Filippatos, Gerasimos S $u University of Cyprus Medical School, Nicosia, Cyprus; Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.
- 700 1_
- $a Gialafos, Elias $u Second Department of Cardiology, Heart Failure and Preventive Cardiology Section, Henry Dunant Hospital, Athens, Greece.
- 700 1_
- $a Kanjuh, Vladimir $u Serbian Academy of Sciences and Arts, Belgrade, Serbia.
- 700 1_
- $a Krljanac, Gordana $u University of Belgrade Faculty of Medicine, Belgrade, Serbia. Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
- 700 1_
- $a Limongelli, Giuseppe $u Department of Cardiothoracic Sciences, Università della Campania 'Luigi VanvitellI', Monaldi Hospital, AORN Colli, Centro di Ricerca Cardiovascolare, Ospedale Monaldi, AORN Colli, Naples, Italy, and UCL Institute of Cardiovascular Science, London, UK.
- 700 1_
- $a Linhart, Aleš $u Second Department of Medicine, Department of Cardiovascular Medicine, General University Hospital, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Lyon, Alexander R $u National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, UK.
- 700 1_
- $a Maksimović, Ružica $u University of Belgrade Faculty of Medicine, Belgrade, Serbia. Centre for Radiology and Magnetic Resonance Imaging, Clinical Centre of Serbia, Belgrade, Serbia.
- 700 1_
- $a Miličić, Davor $u Department of Cardiovascular Diseases, University Hospital Center Zagreb, University of Zagreb, Zagreb, Croatia.
- 700 1_
- $a Milinković, Ivan $u Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
- 700 1_
- $a Noutsias, Michel $u Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle, Halle, Germany.
- 700 1_
- $a Oto, Ali $u Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- 700 1_
- $a Oto, Öztekin $u Department of Cardiovascular Surgery, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
- 700 1_
- $a Pavlović, Siniša U $u University of Belgrade Faculty of Medicine, Belgrade, Serbia. Pacemaker Center, Clinical Center of Serbia, Belgrade, Serbia.
- 700 1_
- $a Piepoli, Massimo F $u Heart Failure Unit, Cardiology, G. da Saliceto Hospital, Piacenza, Italy.
- 700 1_
- $a Ristić, Arsen D $u University of Belgrade Faculty of Medicine, Belgrade, Serbia. Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
- 700 1_
- $a Rosano, Giuseppe M C $u Department of Medical Sciences, IRCCS San Raffaele, Rome, Italy, and Cardiology Clinical Academic Group, St George's Hospitals NHS Trust University of London, London, UK.
- 700 1_
- $a Seggewiss, Hubert $u Medizinische Klinik, Kardiologie & Internistische Intensivmedizin, Klinikum Würzburg-Mitte, Würzburg, Germany.
- 700 1_
- $a Ašanin, Milika $u University of Belgrade Faculty of Medicine, Belgrade, Serbia. Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
- 700 1_
- $a Seferović, Jelena P $u Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center Serbia and Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
- 700 1_
- $a Ruschitzka, Frank $u Department of Cardiology, University Heart Center, Zürich, Switzerland.
- 700 1_
- $a Čelutkiene, Jelena $u Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
- 700 1_
- $a Jaarsma, Tiny $u Department of Social and Welfare Studies, Faculty of Health Science, Linköping University, Linköping, Sweden.
- 700 1_
- $a Mueller, Christian $u Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
- 700 1_
- $a Moura, Brenda $u Cardiology Department, Centro Hospitalar São João, Porto, Portugal.
- 700 1_
- $a Hill, Loreena $u School of Nursing and Midwifery, Queen's University Belfast, Belfast, UK.
- 700 1_
- $a Volterrani, Maurizio $u Department of Cardiology, IRCCS San Raffaele Pisana, Rome, Italy.
- 700 1_
- $a Lopatin, Yuri $u Volgograd State Medical University, Regional Cardiology Centre Volgograd, Volgograd, Russia.
- 700 1_
- $a Metra, Marco $u Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
- 700 1_
- $a Backs, Johannes $u Department of Molecular Cardiology and Epigenetics, University of Heidelberg, Heidelberg, Germany. DZHK (German Centre for Cardiovascular Research) partner site Heidelberg/Mannheim, Heidelberg, Germany.
- 700 1_
- $a Mullens, Wilfried $u BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium. Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
- 700 1_
- $a Chioncel, Ovidiu $u University of Medicine Carol Davila, Bucharest, Romania. Emergency Institute for Cardiovascular Diseases, 'Prof. C. C. Iliescu', Bucharest, Romania.
- 700 1_
- $a de Boer, Rudolf A $u Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- 700 1_
- $a Anker, Stefan $u Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany. Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany. DZHK (German Centre for Cardiovascular Research) partner site Berlin, Charité, Berlin, Germany.
- 700 1_
- $a Rapezzi, Claudio $u Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy.
- 700 1_
- $a Coats, Andrew J S $u Monash University, Australia, and University of Warwick, Coventry, UK. Pharmacology, Centre of Clinical and Experimental Medicine, IRCCS San Raffaele Pisana, Rome, Italy, and St George's University of London, London, UK.
- 700 1_
- $a Tschöpe, Carsten $u Berlin-Brandenburg Center for Regenerative Therapies, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Berlin, Department of Cardiology, Campus Virchow Klinikum, Charite - Universitaetsmedizin Berlin, Berlin, Germany.
- 773 0_
- $w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 21, č. 5 (2019), s. 553-576
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30989768 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20230131101215 $b ABA008
- 999 __
- $a ok $b bmc $g 1600013 $s 1116554
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 21 $c 5 $d 553-576 $e 20190416 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
- LZP __
- $a Pubmed-20201125
